scholarly journals Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review

Nutrients ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 1565 ◽  
Author(s):  
Sanne Verhoog ◽  
Petek Eylul Taneri ◽  
Zayne M. Roa Díaz ◽  
Pedro Marques-Vidal ◽  
John P. Troup ◽  
...  

Akkermansia muciniphila and Faecalibacterium prausnitzii are highly abundant human gut microbes in healthy individuals, and reduced levels are associated with inflammation and alterations of metabolic processes involved in the development of type 2 diabetes. Dietary factors can influence the abundance of A. muciniphila and F. prausnitzii, but the evidence is not clear. We systematically searched PubMed and Embase to identify clinical trials investigating any dietary intervention in relation to A. muciniphila and F. prausnitzii. Overall, 29 unique trials were included, of which five examined A. muciniphila, 19 examined F. prausnitzii, and six examined both, in a total of 1444 participants. A caloric restriction diet and supplementation with pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate, and inulin increased the abundance of A. muciniphila, while a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols decreased the abundance of A. muciniphila. For F. prausnitzii, the main studied intervention was prebiotics (e.g. fructo-oligosaccharides, inulin type fructans, raffinose); seven studies reported an increase after prebiotic intervention, while two studies reported a decrease, and four studies reported no difference. Current evidence suggests that some dietary factors may influence the abundance of A. muciniphila and F. prausnitzii. However, more research is needed to support these microflora strains as targets of microbiome shifts with dietary intervention and their use as medical nutrition therapy in prevention and management of chronic disease.

2009 ◽  
pp. 245-260
Author(s):  
Olga Kordonouri ◽  
Caroline Apovian ◽  
Lauren Kuhn ◽  
Thomas Danne ◽  
Christos S. Mantzoros

2015 ◽  
Vol 03 (01) ◽  
pp. 061-063
Author(s):  
Sandra Scrivens

AbstractWith global obesity affecting 475 million people worldwide, the continued popularity of celebrity or fad diets is not surprising. Evidence for their sustainability and long-term positive benefits on weight loss and cardiometabolic risk is, however, limited. Modest weight loss of 5-10% in overweight or obesity is associated with improvements in blood lipids, glycemia, and insulin resistance. As overweight and obesity are the main risk factors for Type 2 diabetes (T2DM), medical nutrition therapy based on a balanced, reduced total energy diet, tailored to the individual, is recommended by the American Diabetes Association, Diabetes UK and transcultural diabetes-specific nutrition algrorithm (tDNA) guidelines.


2017 ◽  
Vol 117 (10) ◽  
pp. 1578-1611 ◽  
Author(s):  
Hollie A. Raynor ◽  
Patricia G. Davidson ◽  
Heather Burns ◽  
Micki D. Hall Nadelson ◽  
Shelley Mesznik ◽  
...  

2009 ◽  
Vol 35 (6) ◽  
pp. 1004-1013 ◽  
Author(s):  
Otilia Perichart-Perera ◽  
Margie Balas-Nakash ◽  
Adalberto Parra-Covarrubias ◽  
Ameyalli Rodriguez-Cano ◽  
Aurora Ramirez-Torres ◽  
...  

2013 ◽  
Vol 4 (2) ◽  
pp. 127-139
Author(s):  
Vincent Wing-Ming Wong

Gestational diabetes mellitus (GDM) is a condition that affects the wellbeing of mother and fetus. Women with GDM are at risk of type 2 diabetes mellitus in the future, while fetal exposure to hyperglycaemia in-utero may affect their glycometabolic profile later in life. Appropriate screening and management of this problem is important in ensuring good pregnancy outcomes. In this review, the clinical implications, the various ways to screen and diagnose GDM, and management strategies during pregnancy will be discussed. For years, insulin is the mainstay of treatment if medical nutrition therapy fails to maintain adequate glycaemic control, but use of other oral pharmacotherapy may gain greater acceptance in the future. Following delivery, ongoing follow-up of these women is worthwhile as early intervention through lifestyle or pharmacotherapy may prevent the development of diabetes.


Author(s):  
Gulfam Ahmad Cheema

Medical nutrition therapy remains the cornerstone in chronic disease management, apart from medication and regular physical activity. Various clinical practice guidelines and position papers from worldwide associations have incorporated specific nutrition recommendations in managing chronic diseases such as diabetes mellitus, hypertension, hyperlipidaemia, gout and chronic renal failure, which aim to prevent further complications or other co-morbidities arise from these chronic medical conditions. In addition, specific issues such as carbohydrate exchange, glycaemic index and glycaemic load for people with diabetes; DASH diet for hypertensive individuals, latest concerns on trans-fat, the usage of plant sterol and soluble fibre in enhancing lipid lowering will also be addressed in this article.


2021 ◽  
Vol 22 (3) ◽  
pp. 197-200
Author(s):  
Yoon Seok Choi

Type 2 diabetes mellitus becomes increasingly more common with age. As such, older adults represent a very heterogeneous group in terms of functional ability and cognitive status. Older adults with diabetes are distinct from younger adults with diabetes, leading to differences in therapeutic approach. Some important goals of nutrition therapy in older adults with diabetes include minimizing hypoglycemia and hyperglycemia and meeting individualized glycemic goals. Nutrition therapy for older adults with diabetes should include meeting the nutritional needs for patients while considering their age, evaluating their fluid intake, avoiding significant weight loss, and being sensitive to individual preferences and long standing food habits while advocating good nutrition. However, there is little evidence for nutritional guidelines for older adults with diabetes, thus more research is needed.


Sign in / Sign up

Export Citation Format

Share Document